Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron May 02, 2023 4:01pm
134 Views
Post# 35425938

RE:Sure would be nice

RE:Sure would be nice

DJDawg wrote:
While I believe in the science it sometimes feels like the company management is absent.

It would be great if they could parse out some helpful updates to support the share price a bit. I'm not selling but it does feel disheartening to see all these price drops without any efforts to bump up the positives by the company. I totally get that there are no new investors at this time as they have not spread the word very well. I totally see that the clinical data is hard to be excited about unless you truly understand how novel the therapy is. I just wish for a bit more price stability while we wait. I have heard others comment that the company would be further along with all projects if they were more skilled at raising money. I kind of agree. I have seen so many Biotechs raise huge sums off animal data alone. Why can't this company try a bit harder.

Just venting.

Who knows, maybe they will surprise us but so far the science is doing the work and the company management is quite disappointing.

 

We are on a skeleton crew...I'm not sure who is actually managing, or is eligible to manage at this point in time?

<< Previous
Bullboard Posts
Next >>